BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Nosology
,
Doxorubicin
,
rs4950928
,
LEP
,
T cell receptor signaling pathway
,
Hippocampus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
meglitinide
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Synthesis and biological investigations of nitric oxide releasing nateglinide and meglitinide type I…
Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implication…
Spermicidal activity of sulfonylureas and meglitinide analogues: role of intrasperm Ca2+ elevation.
Glinides].
Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabete…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Incretin-based Drugs and Pancreatic Cancer
Incretin-based Drugs and the Risk of Heart Failure
Incretin-based Drugs and Acute Pancreatitis
Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add…
Molecular Mechanisms of Type 2 Diabetes Mellitus
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ